BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

371 related articles for article (PubMed ID: 28108550)

  • 1. Cardiac resynchronization therapy in adults with congenital heart disease.
    Koyak Z; de Groot JR; Krimly A; Mackay TM; Bouma BJ; Silversides CK; Oechslin EN; Hoke U; van Erven L; Budts W; Van Gelder IC; Mulder BJM; Harris L
    Europace; 2018 Feb; 20(2):315-322. PubMed ID: 28108550
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluating the response to cardiac resynchronization therapy performed with a new ventricular morphology-based strategy for congenital heart disease.
    Miyazaki A; Negishi J; Hayama Y; Baba S; Matsumura Y; Shima Y; Tsuda E; Sakaguchi H; Hoashi T; Kagisaki K; Noda T; Doi H; Ichikawa H; Ohuchi H
    Heart Vessels; 2019 Aug; 34(8):1340-1350. PubMed ID: 30863899
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiac resynchronization therapy in patients with end-stage hypertrophic cardiomyopathy.
    Killu AM; Park JY; Sara JD; Hodge DO; Gersh BJ; Nishimura RA; Asirvatham SJ; McLeod CJ
    Europace; 2018 Jan; 20(1):82-88. PubMed ID: 29315424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-Term Outcomes of Cardiac Resynchronization Therapy in Patients With Repaired Tetralogy of Fallot: A Multicenter Study.
    Ramdat Misier NL; Moore JP; Nguyen HH; Lloyd MS; Dubin AM; Mah DY; Czosek RJ; Khairy P; Chang PM; Nielsen JC; Aydin A; Pilcher TA; O'Leary ET; Shivkumar K; de Groot NMS
    Circ Arrhythm Electrophysiol; 2024 Mar; 17(3):e012363. PubMed ID: 38344811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term outcome of patients with and without super-response to CRT-D.
    Franke J; Keppler J; Abadei AK; Bajrovic A; Meme L; Zugck C; Raake PW; Zitron E; Katus HA; Frankenstein L
    Clin Res Cardiol; 2016 Apr; 105(4):341-8. PubMed ID: 26497005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Usefulness of notched duration to predict response to cardiac resynchronization therapy.
    Balci MM; Balci KG; Sen F; Maden O; Unal S; Selcuk MT; Selcuk H
    Scand Cardiovasc J; 2015 Aug; 49(4):200-6. PubMed ID: 25920477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 16 Years of Cardiac Resynchronization Pacing Among Congenital Heart Disease Patients: Direct Contractility (dP/dt-max) Screening When the Guidelines Do Not Apply.
    Karpawich PP; Bansal N; Samuel S; Sanil Y; Zelin K
    JACC Clin Electrophysiol; 2017 Aug; 3(8):830-841. PubMed ID: 29759779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal function impairment predicts mortality in patients with chronic heart failure treated with resynchronization therapy.
    Gronda E; Genovese S; Padeletti L; Cacciatore F; Vitale DF; Bragato R; Innocenti L; Schiano C; Sommese L; De Pascale MR; Genovese L; Abete P; Donatelli F; Napoli C
    Cardiol J; 2015; 22(4):459-66. PubMed ID: 26325259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Right ventricular function assessed by cardiac magnetic resonance predicts the response to resynchronization therapy.
    Manca P; Cossa S; Matta G; Scalone A; Tola G; Schintu B; Setzu A; Melis M; Giardina A; Corda M; Sinagra G; Porcu M
    J Cardiovasc Med (Hagerstown); 2020 Apr; 21(4):299-304. PubMed ID: 32108126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel electrocardiographic dyssynchrony criteria improve patient selection for cardiac resynchronization therapy.
    Vereckei A; Szelényi Z; Kutyifa V; Zima E; Szénási G; Kiss M; Katona G; Karádi I; Merkely B
    Europace; 2018 Jan; 20(1):97-103. PubMed ID: 28011802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implantation feasibility, procedure-related adverse events and lead performance during 1-year follow-up in patients undergoing triple-site cardiac resynchronization therapy: a substudy of TRUST CRT randomized trial.
    Lenarczyk R; Kowalski O; Sredniawa B; Pruszkowska-Skrzep P; Mazurek M; Jędrzejczyk-Patej E; Woźniak A; Pluta S; Głowacki J; Kalarus Z
    J Cardiovasc Electrophysiol; 2012 Nov; 23(11):1228-36. PubMed ID: 22651239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of clinical outcome in patients treated with cardiac resynchronization therapy - the role of NT-ProBNP and a combined response score.
    Bakos Z; Chatterjee NC; Reitan C; Singh JP; Borgquist R
    BMC Cardiovasc Disord; 2018 Apr; 18(1):70. PubMed ID: 29699498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. T-wave area predicts response to cardiac resynchronization therapy in patients with left bundle branch block.
    Engels EB; Végh EM; Van Deursen CJ; Vernooy K; Singh JP; Prinzen FW
    J Cardiovasc Electrophysiol; 2015 Feb; 26(2):176-83. PubMed ID: 25230363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Longer right to left ventricular activation delay at cardiac resynchronization therapy implantation is associated with improved clinical outcome in left bundle branch block patients.
    Kosztin A; Kutyifa V; Nagy VK; Geller L; Zima E; Molnar L; Szilagyi S; Ozcan EE; Szeplaki G; Merkely B
    Europace; 2016 Apr; 18(4):550-9. PubMed ID: 26116830
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Machine Learning Prediction of Response to Cardiac Resynchronization Therapy: Improvement Versus Current Guidelines.
    Feeny AK; Rickard J; Patel D; Toro S; Trulock KM; Park CJ; LaBarbera MA; Varma N; Niebauer MJ; Sinha S; Gorodeski EZ; Grimm RA; Ji X; Barnard J; Madabhushi A; Spragg DD; Chung MK
    Circ Arrhythm Electrophysiol; 2019 Jul; 12(7):e007316. PubMed ID: 31216884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Three-dimensional interlead distance predicts response and outcomes after cardiac resynchronization therapy.
    Clementy N; Laborie G; Pierre B; Benhenda N; Babuty D; Fauchier L
    Arch Cardiovasc Dis; 2017 Nov; 110(11):590-598. PubMed ID: 28734687
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early and Late Effects of Cardiac Resynchronization Therapy in Adult Congenital Heart Disease.
    Yin Y; Dimopoulos K; Shimada E; Lascelles K; Griffiths S; Wong T; Gatzoulis MA; Babu-Narayan SV; Li W
    J Am Heart Assoc; 2019 Nov; 8(21):e012744. PubMed ID: 31657270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional response to cardiac resynchronization therapy is associated with improved clinical outcome and absence of appropriate shocks.
    Van Boven N; Bogaard K; Ruiter J; Kimman G; Theuns D; Kardys I; Umans V
    J Cardiovasc Electrophysiol; 2013 Mar; 24(3):316-22. PubMed ID: 23210664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiac resynchronization therapy in patients with congenital heart disease and systemic right ventricle.
    Jacquemart E; Combes N; Duthoit G; Bessière F; Ladouceur M; Iserin L; Laredo M; Bredy C; Maltret A; Di Filippo S; Hascoët S; Pasquié JL; Marijon E; Waldmann V
    Heart Rhythm; 2022 Apr; 19(4):658-666. PubMed ID: 34863963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reverse electrical remodeling by cardiac resynchronization therapy: prevalence and clinical impact.
    Sebag FA; Martins RP; Defaye P; Hidden-Lucet F; Mabo P; Daubert JC; Leclercq C
    J Cardiovasc Electrophysiol; 2012 Nov; 23(11):1219-27. PubMed ID: 22697464
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.